Drugs (Pharmaceuticals) – Page 63

Covid Vaccine Makers Kept Prepayments for Canceled Shots for Poor Nations

Separately, Johnson & Johnson is demanding additional payment for unwanted shots, confidential documents show.

By Stephanie Nolen and Rebecca Robbins

Antitrust Laws and Competition Issues Drugs (Pharmaceuticals) Humira (Drug) Intellectual Property Inventions and Patents Prices (Fares, Fees and Rates) Suits and Litigation (Civil)

How a Drug Company Made $114 Billion by Gaming the U.S. Patent System

AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.

By Rebecca Robbins

Drugs (Pharmaceuticals) Electronic Health Records Paradigm Research Start-ups Thoelke, Kent

Start-Up Raises $200 Million to Speed Up Drug Trials

New York-based Paradigm has raised a significant amount to simplify clinical trials. Its goal is ambitious, but its challenges are many, researchers say.

By Maureen Farrell

Drugs (Pharmaceuticals) Federal-State Relations (US) Food and Drug Administration GenBioPro Law and Legislation Regulation and Deregulation of Industry States (US) Suits and Litigation (Civil)

New Lawsuit Challenges State Bans on Abortion Pills

The case, brought by GenBioPro, a company that makes one of two abortion drugs, argues that it is unconstitutional for a state to bar access to a medication approved by the federal government.

By Pam Belluck